Every open market buy and sale of Ultragenyx Pharmaceutical Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $3.8M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when RARE insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an RARE officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every RARE insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Howard HornCFO | Sale | 7,066 | $15.27 | $108K | 89,229 | Oct 19Form 4 |
| Sep 15, 2026 | Theodore Alan HuizengaSVP, Chief Accounting Officer | Sale plan | 1,283 | $13.57 | $17K | 67,863 | Sep 15Form 4 |
| Sep 3, 2026 | Theodore Alan HuizengaSVP, Chief Accounting Officer | Sale | 161 | $13.99 | $2K | 69,146 | Sep 8Form 4 |
| Aug 3, 2026 | Howard HornCFO | Sale plan | 4,696 | $24.92 | $117K | 96,295 | Aug 4Form 4 |
| Aug 3, 2026 | Karah Herdman ParschauerEVP and Chief Legal Officer | Sale plan | 1,900 | $24.92 | $47K | 92,562 | Aug 4Form 4 |
| Jul 1, 2026 | Howard HornCFO | Sale plan | 4,698 | $33.13 | $156K | 100,991 | Jul 6Form 4 |
| Jun 15, 2026 | Karah Herdman ParschauerEVP and Chief Legal Officer | Sale plan | 1,899 | $24.62 | $47K | 94,462 | Jun 15Form 4 |
| Jun 15, 2026 | Corazon (Corsee) D. SandersDirector | Sale | 2,000 | $25.05 | $50K | 21,095 | Jun 15Form 4 |
| Jun 1, 2026 | Howard HornCFO | Sale plan | 4,653 | $23.77 | $111K | 105,689 | Jun 1Form 4 |
| May 18, 2026 | Shehnaaz SulimanDirector | Sale plan | 5,740 | $25.12 | $144K | 27,951 | May 18Form 4 |
| May 5, 2026 | Eric CrombezEVP and Chief Medical Officer | Sale | 344 | $24.96 | $9K | 111,189 | May 6Form 4 |
| May 1, 2026 | Howard HornCFO | Sale plan | 4,683 | $24.90 | $117K | 110,342 | May 4Form 4 |
| Apr 1, 2026 | Howard HornCFO | Sale plan | 4,683 | $20.97 | $98K | 80,351 | Apr 2Form 4 |
| Mar 10, 2026 | Karah Herdman ParschauerEVP and Chief Legal Officer | Sale | 9,526 | $21.87 | $208K | 66,820 | Mar 10Form 4 |
| Mar 3, 2026 | Howard HornCFO | Sale plan | 10,044 | $22.65 | $228K | 85,034 | Mar 3Form 4 |
RARE insider trading FAQ
Are RARE insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of RARE on the open market in 0 trades, and 9 sold $3.8M in 25 trades, 35% of that under pre-arranged trading plans.
When did an RARE insider last buy shares?
There has been no open market insider purchase of RARE in the last two years.
When did an RARE insider last sell shares?
Howard Horn (CFO) sold 7,066 shares for $108K on Oct 15, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
